Naveed Sattar

The study is small and imperfect but offers more data on how time-restricted diets work.

Drinking 2 L or more of artificially sweetened drinks per week was associated with a 20% increased risk for atrial fibrillation in a new observational study.

Prespecified analysis of the STEP-HFpEF trial of semaglutide in people with obesity and heart failure with preserved ejection fraction showed a positive link between weight-loss amounts and outcomes.

Researchers estimate that 500,000 individuals were unable to receive blood pressure-lowering medications during the pandemic. According to a study recently published in Nature Medicine and supported by the British Heart Foundation (BHF) Data Science Centre at Health Data Research UK, approximately

'Given the impact type 2 diabetes will have on people's lives, preventing — or at least delaying the onset — of the condition should be an urgent priority,' says a study author.

The late-stage trial showed that patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a...

Top-line results show semaglutide for weight loss (Wegovy) cut cardiovascular events in the 17,000-person SELECT CV outcomes trial, which should reframe the health benefit of this weight loss drug.

Researchers say they may be able to explain how light drinking benefits the heart, and its main effect doesn't stem from changes in the blood – as scientists once thought – but from its actions in the brain.

If you don't eat many vegetables or fruits or drink tea, you could be low in flavanols that may preserve your aging memory — but don't look to chocolate for help.

The first small-molecule glucagon-like peptide 1 receptor agonist to complete a phase 3 trial lowers A1c and reduces weight, the company says.

Use of the weight loss drug tirzepatide was noted on the death certificate of a Scottish nurse, but experts say clinical trials have demonstrated an acceptable safety record.

Cambridge-led study of 2m people globally is most comprehensive evidence yet of red meat link to diabetes

Published cost-effectiveness analyses of GLP-1 receptor agonists for obesity and diabetes have shown mixed results, but their wide-ranging benefits may have been sold short.

An analysis of over 500,000 Americans found no increase in the risk for early death for people officially defined as overweight, but risk went up as weight increased.

People of South Asian ethnicity may be able to achieve type 2 diabetes remissions by following a structured weight management program, according to a new study which saw one third of participants lose more than 10% of their body weight.

Study into medication known as 'King Kong' of weight loss drugs throws fresh light on effects of longer-term use

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

The anti-obesity drug is associated with significant reductions in a key inflammatory marker linked to major cardiovascular events, according to SELECT clinical trial investigators.

The European Congress on Obesity conference in Venice also hears about how financial incentives could help men lose weight

An analysis of over 500,000 Americans found no increase in the risk for early death for people officially defined as overweight, but risk went up as weight...